News

Clifton Mining Company: Highlights from Recent Voting Results

Clifton Mining Company: Highlights from Recent Voting Results

Clifton Mining Company's Annual Meeting Highlights

Recently, Clifton Mining Company (OTCBB: CFTN) conducted an annual meeting to review important matters concerning its direction and leadership. During this meeting, shareholders actively participated, and the results showcased robust support for the company's strategic path ahead.

Director Nominees and Voting Results

Within the meeting, shareholders approved the election of all six director nominees put forth. Each nominee received a noteworthy level of support from the shareholders, reflecting confidence in the company’s leadership. The affirmative votes were calculated from a quorum of approximately 64%, excluding abstentions and broker non-votes. Here's a brief overview of the nominees and their respective vote percentages:

Nominees Approved

1. **Jessica Marr (Term expiring 2026)** - Received an approval of 78%
2. **Michael Marr (Term expiring 2027)** - Received an approval of 79%
3. **Erica Marr (Term expiring 2027)** - Received an approval of 78%
4. **K. Bruce Jones (Term expiring 2028)** - Received an impressive 89%
5. **Kenneth S. Friedman (Term expiring 2028)** - Gained a 66% approval
6. **Scott S. Moeller (Term expiring 2028)** - Achieved 65% approval.

Appointment of Independent Auditors

In addition to the election results, shareholders ratified the appointment of Sadler, Gibb & Associates, LLC as the company’s independent auditors. This decision saw an impressive 90% of shares voting in favor, illustrating the trust investors hold in Clifton Mining Company’s financial oversight.

Updates from Company Leadership

During the gathering, several reports were given. Michael Marr provided insights on his experiences as an investor in both commercial real estate and the mining sector. He discussed how his journey has linked him to Clifton Mining Company and its activities. Moreover, he shared optimistic updates about Desert Hawk Gold Corp., noting that its operations are yielding about six ounces of gold daily while remaining cash flow positive.

Furthermore, Ken Friedman highlighted a significant shift in precious metal pricing, emphasizing how this has prompted a strategic pivot for Clifton Mining. The company is now focusing on seeking partnerships to further explore and develop the mineral-rich Clifton Shear Zones.

Lastly, Paul Schwitzer, Vice President of Marketing and Sales for American Biotech Labs, updated participants on product sales projections, indicating a positive trajectory. Notably, sales through Amazon have continued to flourish, with many first-time users opting for repeat purchases.

Conclusion of the Meeting

The meeting concluded around 2:30 PM, with a sense of direction and optimism among attendees. Clifton Mining Company is poised for growth and exploration with the recent approval of its directors and the strategic choices surrounding precious metals.

Clifton Mining Company trades under the symbol CFTN on the OTC Markets. As the company progresses, both investors and stakeholders are keenly watching its developments.

Frequently Asked Questions

What were the results of the recent annual meeting?

The results included the approval of all six director nominees and the ratification of Sadler, Gibb & Associates, LLC as independent auditors.

How did shareholders react to the elections?

Shareholders demonstrated strong support, with notable percentages indicating confidence in the elected directors.

What key updates were shared during the meeting?

Updates included progress on Desert Hawk Gold Corp. and a strategic shift in Clifton Mining's approach towards developing mineral resources.

What is the significance of the auditor's appointment?

The appointment of Sadler, Gibb & Associates, LLC signifies shareholders' trust in the company's financial management amidst ongoing operations.

What does the future hold for Clifton Mining Company?

With leadership approved and strategic directions set, the future appears promising as Clifton Mining seeks to explore and develop its mineral properties.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Market Shake-Up: GDP Climbs, Stocks Dive

Updated Category News Views 114

See the Forest, Amid the Trees Alright, folks, the market's mood swings faster than a teenager's. Despite a third-quarter GDP growth punching 3.4% up from 2.2% last quarter, stocks took a nosedive Thursday morning. The S&P 500 tanked 3.39%, Nasdaq sank 5.08%, and even the stodgy Dow dropped 2.37%. Yet, don't let the red on the screen fool you—year-to-date gains are...

Continue Reading
Lynk's Zemprocitinib Set for RA Markets: NDA Accepted

Updated Category News Views 101

A Step Closer for Zemprocitinib: Here's the Lowdown Surprise in the pharma skies as Lynk Pharmaceuticals takes a major leap with its new gem, zemprocitinib, entering the regulatory review phase. The center buzzed on November 4 when China's NMPA gave the coveted nod to this New Drug Application (NDA). Seems the race for rheumatoid arthritis (RA) treatments just got a...

Continue Reading
Norwegian Cruise Line's Black Friday Big Splash

Updated Category News Views 126

Jump Aboard NCL's Black Friday Bargain Ship Grab your life jackets, folks! Norwegian Cruise Line (NCL) is sailing with an irresistible Black Friday offer: 50% off all cruises, complete with their much-lauded Free at Sea package. Yeah, if you've been fence-sitting about taking the plunge into the cruise lifestyle, now might just be the time to buckle up your life vests. A...

Continue Reading
Research Solutions Set to Reveal Q1 FY27 Results

Updated Category News Views 68

Understanding the Stakes Ahead of RSSS's Earnings Call Aw, the sweet suspense of earnings season. Research Solutions, Inc. (NASDAQ: RSSS) has circled November 12, 2026, as the date to let investors in on its numbers for the first quarter of fiscal year 2027. A date that's gotta have the folks over at RSSS feeling like it’s judgment day. You know how it goes—market...

Continue Reading
Intensity Therapeutics: Q3 Results Show Steady Progress

Updated Category News Views 104

Patient Enrollment Back on Track Today feels like we're talking about a company that's finally shaking off the cobwebs—Intensity Therapeutics is back in action with their cancer trials. After hitting the brakes back in March 2025 thanks to a cash crunch, it looks like Intensity is revving up once more, thanks to some better financial footing. They've got their Phase 3...

Continue Reading
Hexagon Composites Q3 2026: Demand Boosts Revenues

Updated Category News Views 99

I bet Hexagon's investors are waking up with a grin today. These guys made a cool NOK 929 million in revenue for Q3 2026, leaping up from NOK 538 million last year. Now, ain't that a sight for sore eyes? They posted a NOK 108 million EBITDA while grumbling was swapped with a 12% margin—no longer in the red. Breaking Down Hexagon's Climb Hexagon Composites (OSE: HEX.OL)...

Continue Reading
Vermiculus Taps New CISO Amid Index Engine Launch

Updated Category News Views 46

Vermiculus Ups Its Security Game You ever wonder why a company decides to beef up security? Well, Vermiculus ain't leaving anything to chance as they roll out new tech. They've named Alexander Kilian the Chief Information Security Officer. Yep, Kilian's stepping into the ring, and no one’s treating this like a sidebar gig. This market tech outfit isn't just polishing...

Continue Reading
Koozee Boosts Apparel Design with AI Workflows

Updated Category News Views 108

Revolutionizing Apparel Design with AI If you've ever wondered how tech can make an impact on the fashion world, Koozee's latest update provides an eye-opening look. This isn't about following trends—it's about setting them, and Koozee’s making a bold move with its newest platform enhancements. Introducing Freeform Canvas Koozee has launched the Freeform Canvas, a...

Continue Reading
Real Estate Sage: Tad Barber's Tips on Selling Your Home

Updated Category News Views 173

Kicking Off the 2027 Home Selling Game Plan Let me tell you, the real estate world isn't for the faint-hearted. It’s a realm where a solid game plan makes a world of difference, especially when you're thinking about selling your home in 2027. In Aiken, South Carolina, it seems the local know-it-all Tad Barber has teamed up with HelloNation to throw down some insight on...

Continue Reading
Sharon Bowen Honored; e.l.f. Beauty Hits 31 Quarters

Updated Category News Views 185

Markets Stir as NYSE Chair Earns Lifetime Award While the financial world often gets lost in numbers, sometimes it's the people who stand out. NYSE Chair Sharon Bowen is taking the spotlight with her lifetime achievement award, underscoring her game-changing influence in governance. This is more than just a pat on the back; it's a nod to the force she’s been in steering...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Future of Web3: Insights from KuCoin's Panel

Updated Category News Views 148

Insights into Web3 Development At a recent gathering during Hackseason, KuCoin's Managing Director, Alicia Kao, moderated a significant panel that explored the direction of Web3 technologies. The panel featured distinguished voices from the blockchain and Web3 sectors, highlighting their expertise and collaborative spirit. The session, aptly titled "Where is Web3 Headed...

Continue Reading
Crypto Losses Are Reshaping Investor Behavior, and the Market Itself

Updated Category Crypto Views 169

About a third of cryptocurrency investors have reportedly cut their daily spending due to digital asset losses. Research demonstrates that people who lose money in crypto experience more than temporary discomfort, highlighting a concrete link between crypto markets and the real world. The market decline, which has persisted for some time, is the main reason behind this...

Continue Reading
Crest Holdings Group's Vision and Leadership by Antwain Baker

Updated Category News Views 182

Leadership Insights of Antwain Baker at Crest Holdings Group LLC Crest Holdings Group LLC recently highlighted its leadership journey and vision under the guidance of Founder and CEO Antwain Baker. This Atlanta-based consulting and holding firm is dedicated to enhancing business operations across various sectors. The Approach of Antwain Baker With a rich background in...

Continue Reading
Celebrating Half a Century of Excellence at Katsky Korins Firm

Updated Category News Views 204

Katsky Korins Marks 50 Years of Legal Excellence "Humanity is our X Factor" Katsky Korins, a distinguished law firm based in New York City, proudly announces its milestone of celebrating 50 years of dedicated service in the legal profession. Established in 1975, it stands as one of the longest-serving general practice law firms in the bustling city, earning a remarkable...

Continue Reading
Seres Therapeutics Enhances SER-155 Study Protocol Amid Cost Cuts

Updated Category News Views 232

Seres Therapeutics Makes Significant Progress with SER-155 Recently, Seres Therapeutics has received valuable feedback from regulatory authorities, which is paving the way for the completion of its important SER-155 Phase 2 study protocol. This study focuses on preventing bloodstream infections in adults who are undergoing allogeneic hematopoietic stem cell transplant for...

Continue Reading